Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors.
Hamann MV, Beschorner N, Vu XK, Hauber I, Lange UC, Traenkle B, Kaiser PD, Foth D, Schneider C, Büning H, Rothbauer U, Hauber J.
Hamann MV, et al. Among authors: rothbauer u.
PLoS One. 2021 Dec 20;16(12):e0261269. doi: 10.1371/journal.pone.0261269. eCollection 2021.
PLoS One. 2021.
PMID: 34928979
Free PMC article.